IL110074A0 - Fucosylated glycosides as inhibitors of bacterial adherence - Google Patents
Fucosylated glycosides as inhibitors of bacterial adherenceInfo
- Publication number
- IL110074A0 IL110074A0 IL11007494A IL11007494A IL110074A0 IL 110074 A0 IL110074 A0 IL 110074A0 IL 11007494 A IL11007494 A IL 11007494A IL 11007494 A IL11007494 A IL 11007494A IL 110074 A0 IL110074 A0 IL 110074A0
- Authority
- IL
- Israel
- Prior art keywords
- fucosylated
- glycosides
- inhibitors
- bacterial adherence
- adherence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK93761A DK76193D0 (da) | 1993-06-25 | 1993-06-25 | Kulhydratderivater |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL110074A0 true IL110074A0 (en) | 1994-10-07 |
Family
ID=8097261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11007494A IL110074A0 (en) | 1993-06-25 | 1994-06-21 | Fucosylated glycosides as inhibitors of bacterial adherence |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0706528A1 (fr) |
| JP (1) | JPH08512026A (fr) |
| AU (1) | AU7089194A (fr) |
| CA (1) | CA2164961A1 (fr) |
| DK (1) | DK76193D0 (fr) |
| IL (1) | IL110074A0 (fr) |
| IS (1) | IS4181A (fr) |
| LT (1) | LT3446B (fr) |
| WO (1) | WO1995000527A1 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204431B1 (en) | 1994-03-09 | 2001-03-20 | Abbott Laboratories | Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk |
| JPH1160590A (ja) * | 1997-08-22 | 1999-03-02 | Yakult Honsha Co Ltd | オリゴフコース誘導体又はオリゴラムノース誘導体及びその製造法 |
| SE9901007D0 (sv) * | 1999-03-19 | 1999-03-19 | Thomas Boren | Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence |
| CA2618638C (fr) * | 2005-08-09 | 2014-03-11 | Glycomimetics, Inc. | Inhibiteurs glycomimetiques de lectine pa-il ou de lectine pa-iil, ou lectines pa-il et pa-iil provenant de pseudomonas |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| EP3296310A1 (fr) | 2011-12-22 | 2018-03-21 | GlycoMimetics, Inc. | Composés antagonistes d' e-sélectine, compositions et procédés d' utilisation |
| EP2692740A1 (fr) * | 2012-07-30 | 2014-02-05 | Le Centre National De La Recherche Scientifique | Compositions de glycane, leurs procédés de préparation et leurs utilisations en tant que médicament |
| HUE038423T2 (hu) | 2012-12-07 | 2018-10-29 | Glycomimetics Inc | E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára |
| CN105101972A (zh) * | 2013-01-31 | 2015-11-25 | 先锋国际良种公司 | 用于改善植物生长和产量的合成型脂质几丁寡糖 |
| US10086054B2 (en) * | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
| WO2016089872A1 (fr) | 2014-12-03 | 2016-06-09 | Glycomimetics, Inc. | Inhibiteurs hétérobifonctionnels des e-sélectines et des récepteurs aux chimiokines cxcr4 |
| US11045485B2 (en) | 2016-01-22 | 2021-06-29 | Glycomimetics, Inc. | Glycomimetic inhibitors of PA-IL and PA-IIL lectins |
| WO2017151708A1 (fr) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Méthodes pour le traitement et/ou à la prévention de maladies cardiovasculaires par inhibition de la sélectine e |
| WO2018031445A1 (fr) | 2016-08-08 | 2018-02-15 | Glycomimetics, Inc. | Combinaison d'inhibiteurs des points de contrôle des lymphocytes t avec des inhibiteurs de e-sélectine ou de cxcr4, ou avec des inhibiteurs hétérobifonctionnels de e-sélectine et de cxcr4 |
| WO2018068010A1 (fr) | 2016-10-07 | 2018-04-12 | Glycomimetics, Inc. | Antagonistes de e-sélectine multimériques très puissants |
| EP3596096A1 (fr) | 2017-03-15 | 2020-01-22 | GlycoMimetics, Inc. | Dérivés de galactopyranosyle-cyclohexyle utilisés en tant qu'antagonistes d'e-sélectine |
| WO2019108750A1 (fr) | 2017-11-30 | 2019-06-06 | Glycomimetics, Inc. | Méthodes de mobilisation de lymphocytes infiltrant la moelle et leurs utilisations |
| JP7304863B2 (ja) | 2017-12-29 | 2023-07-07 | グリコミメティクス， インコーポレイテッド | Ｅ－セレクチンおよびガレクチン－３のヘテロ二機能性阻害剤 |
| CA3091454A1 (fr) | 2018-03-05 | 2019-09-12 | Glycomimetics, Inc. | Methodes de traitement de la leucemie aigue myeloide et d'etats pathologiques associes |
| CN112638944A (zh) | 2018-08-23 | 2021-04-09 | 西进公司 | 抗tigit抗体 |
| KR20210110645A (ko) | 2018-12-27 | 2021-09-08 | 글리코미메틱스, 인크. | 갈렉틴-3 억제 c-글리코사이드 |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1603609A (en) * | 1977-04-14 | 1981-11-25 | Chembiomed Ltd | O-protected 2-azido-2-deoxy-glycosyl nitrates |
| FR2509313A1 (fr) * | 1981-07-08 | 1983-01-14 | Choay Sa | Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques |
| DE3220427A1 (de) * | 1982-05-29 | 1983-12-01 | Behringwerke Ag, 3550 Marburg | Ss-d-galactosederivate, verfahren zu ihrer herstellung und ihre verwendung |
| DK17685D0 (da) * | 1985-01-14 | 1985-01-14 | Hans Goeran Magnusson | Glycosidderivater |
| EP0348143A3 (fr) * | 1988-06-21 | 1991-03-13 | MARION LABORATORIES, INC. (a Delaware corporation) | Dérivés de bismuth de phosphates et sulphates de saccharides |
-
1993
- 1993-06-25 DK DK93761A patent/DK76193D0/da not_active Application Discontinuation
-
1994
- 1994-06-17 AU AU70891/94A patent/AU7089194A/en not_active Abandoned
- 1994-06-17 JP JP7502720A patent/JPH08512026A/ja active Pending
- 1994-06-17 EP EP94919945A patent/EP0706528A1/fr not_active Withdrawn
- 1994-06-17 CA CA002164961A patent/CA2164961A1/fr not_active Abandoned
- 1994-06-17 WO PCT/SE1994/000604 patent/WO1995000527A1/fr not_active Application Discontinuation
- 1994-06-21 IL IL11007494A patent/IL110074A0/xx unknown
- 1994-06-22 IS IS4181A patent/IS4181A/is unknown
- 1994-06-27 LT LTIP1978A patent/LT3446B/lt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| LTIP1978A (en) | 1995-01-31 |
| EP0706528A1 (fr) | 1996-04-17 |
| AU7089194A (en) | 1995-01-17 |
| IS4181A (is) | 1994-12-26 |
| LT3446B (en) | 1995-10-25 |
| DK76193D0 (da) | 1993-06-25 |
| JPH08512026A (ja) | 1996-12-17 |
| CA2164961A1 (fr) | 1995-01-05 |
| WO1995000527A1 (fr) | 1995-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL110074A0 (en) | Fucosylated glycosides as inhibitors of bacterial adherence | |
| HU9203033D0 (en) | Inhibitors of leucotriene biosynthesis | |
| AU1301697A (en) | Tyrosin-derivate as alpha-v-integrin inhibitors | |
| AU2067892A (en) | Corrosion inhibitors | |
| AU7447691A (en) | Beverage compositions for human consumption | |
| IL122406A0 (en) | Bacterial inhibition with an oligosaccharide compound | |
| PL324819A1 (en) | Derivatives of 4-mercaptopyrrolidine as inhibitors of farnesil transferase | |
| AU4251993A (en) | Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors | |
| AU5884094A (en) | Sponges of hydrocolloids | |
| AU1933592A (en) | Corrosion inhibitors | |
| AU8292091A (en) | Tnf inhibitors | |
| HU9502497D0 (en) | Use of oligosaccharide glycosides as inhibitors of bacterial adherence | |
| AU2390692A (en) | Beta-glucuronidase inhibitor | |
| AU635415B2 (en) | Use of n-alkyl-lactams as crystallization inhibitors | |
| AU6000794A (en) | Cleansing composition | |
| AU4156993A (en) | Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis | |
| AU6030896A (en) | Methods of inhibiting bacterial sialidase | |
| AU7150991A (en) | Aromatase inhibitors | |
| EP0468789A3 (en) | (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes | |
| AU4479096A (en) | 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 | |
| AU1797392A (en) | Pla2 inhibitors | |
| AU7318396A (en) | Methods of preserving microorganisms | |
| AU2831992A (en) | Skin cleansing compositions | |
| AU7394394A (en) | 3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors | |
| AU2168592A (en) | Ltb4 synthesis inhibitors |